{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T11:26:34Z","timestamp":1751282794992},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,4,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>The development of improved vaccines is considered a high priority in the effort to control tuberculosis (TB) world wide. Results from several studies performed in relevant animal models have demonstrated that Mycobacterium tuberculosis secreted antigens may represent major components of improved TB vaccines. To characterize further the M. tuberculosis secreted antigens as they relate to specific features important for vaccine development, rhesus macaques were immunized with either one of two different preparations containing M. tuberculosis culture filtrate (CF) proteins. These preparations differed in relative protein content and in the presence or absence of lipoarabinomannan. Animals received a total of three monthly intramuscular injections consisting of CF proteins resuspended in RIBI adjuvant and were tested for development of specific antibody and cellular proliferative responses. In addition, all animals were constantly monitored for local and systemic reactions as well as for the development of DTH reactions to intradermal tuberculin injection. Results from this study show that the two CF preparations are relatively safe and immunogenic in non-human primates. These two CF preparations differed in their ability to induce specific antibody responses, but were comparable in their ability to induce specific cellular proliferative responses. Induction of both humoral and cellular responses occurred even in presence of pre-existing antibodies directed against M. tuberculosis antigens. However, these responses appeared to be short-lived. Only one of the four animals produced interferon-gamma (IFN-\u03b3) in response to immunization with CF proteins. No DTH reaction to intradermal tuberculin injection was observed in any immunized animal. Although it is clear that additional studies are required to design strategies for the improvement of the immunogenicity of CF proteins, our observations support the currently accepted view that secreted protein-based preparations may represent promising vaccine candidates for TB.<\/jats:p>","DOI":"10.1046\/j.1365-2249.2000.01075.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:19:33Z","timestamp":1047377973000},"page":"84-91","source":"Crossref","is-referenced-by-count":7,"title":["Immunogenicity and safety of <i>Mycobacterium tuberculosis<\/i> culture filtrate proteins in non-human primates"],"prefix":"10.1093","volume":"119","author":[{"given":"R","family":"Attanasio","sequence":"first","affiliation":[{"name":"Department of Biology, Georgia State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Pehler","sequence":"additional","affiliation":[{"name":"Department of Biology, Georgia State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H M","family":"Mcclure","sequence":"additional","affiliation":[{"name":"Yerkes Regional Primate Research Center, Emory University, Atlanta, GA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,4,5]]},"reference":[{"key":"2022011315015815000_b1","first-page":"149","article-title":"Tuberculosis: a global overview of the situation today","volume":"70","author":"Sudre","year":"1992","journal-title":"Bull World Health Organ"},{"key":"2022011315015815000_b2","first-page":"213","article-title":"Global tuberculosis incidence and mortality during 1990\u20132000","volume":"72","author":"Dolin","year":"1994","journal-title":"Bull World Health Organ"},{"key":"2022011315015815000_b3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"2022011315015815000_b4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0041-3879(76)90015-5","article-title":"Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem","volume":"57","author":"Styblo","year":"1976","journal-title":"Tubercle"},{"key":"2022011315015815000_b5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0962-8479(97)90022-8","article-title":"Tuberculosis vaccines: how close to human testing?","volume":"78","author":"Jacobs","year":"1997","journal-title":"Tuberc Lung Dis"},{"key":"2022011315015815000_b6","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1128\/iai.65.11.4515-4524.1997","article-title":"Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry","volume":"65","author":"Sonnenberg","year":"1997","journal-title":"Infect Immun"},{"key":"2022011315015815000_b7","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/iai.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1997","journal-title":"Infect Immun"},{"key":"2022011315015815000_b8","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","article-title":"Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis","volume":"92","author":"Horwitz","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011315015815000_b9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nm0896-888","article-title":"Vaccination against tuberculosis by DNA injection","volume":"2","author":"Tascon","year":"1996","journal-title":"Nat Med"},{"key":"2022011315015815000_b10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"Huygen","year":"1996","journal-title":"Nat Med"},{"key":"2022011315015815000_b11","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1086\/514132","article-title":"Review: the immune response in human tuberculosis\u2014implications for tuberculosis control","volume":"176","author":"Ellner","year":"1997","journal-title":"J Infect Dis"},{"key":"2022011315015815000_b12","first-page":"502","article-title":"Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis","volume":"85","author":"Roberts","year":"1995","journal-title":"Immunology"},{"key":"2022011315015815000_b13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ajp.1350170202","article-title":"Flow microfluorometric analysis of peripheral blood mononuclear cells from nonhuman primates; correlation of phenotype with immune function","volume":"17","author":"Ansari","year":"1989","journal-title":"Am J Primatol"},{"key":"2022011315015815000_b14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1574-695X.1997.tb01014.x","article-title":"DNA-based immunization induces anti-CD4 antibodies directed primarily to native epitopes","volume":"17","author":"Attanasio","year":"1997","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2022011315015815000_b15","first-page":"1","article-title":"Development of new vaccines for tuberculosis: recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET)","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR"},{"key":"2022011315015815000_b16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1128\/CMR.11.3.514","article-title":"Serum therapy for tuberculosis revisited: reappraisal of antibody-mediated immunity against Mycobacterium tuberculosis","volume":"11","author":"Glatman-Freedman","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"2022011315015815000_b17","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1073\/pnas.95.26.15688","article-title":"A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival","volume":"95","author":"Teitelbaum","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011315015815000_b18","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infect Immun"},{"key":"2022011315015815000_b19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/iai.59.2.665-670.1991","article-title":"Human immune response to Mycobacterium tuberculosis antigens","volume":"59","author":"Havlir","year":"1991","journal-title":"Infect Immun"},{"key":"2022011315015815000_b20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/infdis\/166.1.186","article-title":"Secreted antigens of Mycobacterium tuberculosis: characterization with T lymphocytes from patients and contacts after two-dimensional separation","volume":"166","author":"Daugelat","year":"1992","journal-title":"J Infect Dis"},{"key":"2022011315015815000_b21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/1074-7613(94)90007-8","article-title":"Evidence for a superantigen in human tuberculosis","volume":"1","author":"Ohmen","year":"1994","journal-title":"Immunity"},{"key":"2022011315015815000_b22","first-page":"27","article-title":"A cartilage-mimicking T-cell epitope on a 65K mycobacterial heat-shock protein: adjuvant arthritis as a model for human rheumatoid arthritis","volume":"145","author":"Van Eden","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"key":"2022011315015815000_b23","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"2022011315015815000_b24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-3083.1997.d01-99.x","article-title":"Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non- tuberculous mycobacteria belonging to the MAIS-group","volume":"46","author":"Lozes","year":"1997","journal-title":"Scand J Immunol"},{"key":"2022011315015815000_b25","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0264-410X(98)00124-8","article-title":"The effect of heterologous immunity upon the apparent efficacy (e.g. BCG) vaccines","volume":"16","author":"Fine","year":"1998","journal-title":"Vaccine"},{"key":"2022011315015815000_b26","first-page":"1","article-title":"The humoral immune response in tuberculosis: its nature, biological role and diagnostic usefulness","volume":"21","author":"Grange","year":"1984","journal-title":"Adv Tuberc Res"},{"key":"2022011315015815000_b27","first-page":"662","article-title":"The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay","volume":"135","author":"Daniel","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2022011315015815000_b28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0197-2456(94)90042-6","article-title":"Field trials of tuberculosis vaccines: how could we have done them better?","volume":"15","author":"Comstock","year":"1994","journal-title":"Control Clin Trials"},{"key":"2022011315015815000_b29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/iai.52.1.293-302.1986","article-title":"Properties of proteins MBP64, MBP70, and MBP80 of Mycobacterium bovis BCG","volume":"52","author":"Harboe","year":"1986","journal-title":"Infect Immun"},{"key":"2022011315015815000_b30","first-page":"197","article-title":"Bacterial diseases of nonhuman primates","volume-title":"The comparative pathology of zoo animals","author":"McClure","year":"1980"},{"key":"2022011315015815000_b31","first-page":"1335","author":"Kaufmann","year":"1998"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2000.01075.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.2000.01075.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/119\/1\/84\/42181918\/j.1365-2249.2000.01075.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/119\/1\/84\/42181918\/j.1365-2249.2000.01075.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:46:34Z","timestamp":1676375194000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/119\/1\/84\/6461864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,4,5]]},"published-print":{"date-parts":[[2002,4,5]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.2000.01075.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,1]]},"published":{"date-parts":[[2000,1]]}}}